American Society for Clinical Laboratory Science

New Members Named to the ABMS Board of Directors

Retrieved on: 
Mardi, juillet 11, 2023
American Board of Medical Specialties, American Society for Clinical Laboratory Science, ABMS, American Board of Pathology, Professional, Certification, American Medical Association, Medical specialty, American Board of Commissioners for Foreign Missions, Physician, Patient, Executive Committee, American Society for Clinical Pathology, Accreditation, Knowledge, Accreditation Council, Chair, Management, MD, Pathology

CHICAGO, July 11, 2023 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization overseeing certification of physicians and medical specialists in the United States, is pleased to announce the election of Rebecca L. Johnson, MD, former Chief Executive Officer of the American Board of Pathology, as the new Chair of the ABMS Board of Directors. In addition, three new members were also elected to serve on Board of Directors at the ABMS Board meeting held in late June.

Key Points: 
  • CHICAGO, July 11, 2023 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization overseeing certification of physicians and medical specialists in the United States, is pleased to announce the election of Rebecca L. Johnson, MD, former Chief Executive Officer of the American Board of Pathology, as the new Chair of the ABMS Board of Directors .
  • In addition, three new members were also elected to serve on Board of Directors at the ABMS Board meeting held in late June.
  • "For 90 years, ABMS has relied upon the knowledge and experience of dedicated volunteer leaders to ensure that ABMS board certification represents a high standard for professional self-regulation," stated Richard E. Hawkins, MD, ABMS President and Chief Executive Officer.
  • "We welcome our three newest Board Members and look forward to working with them and Dr. Johnson in advancing the importance of board certification for the profession and the patients and communities we serve."

LetsGetChecked Names Avni Santani, PhD, FACMG, Chief Genomics Officer Following Acquisition of Veritas Genetics

Retrieved on: 
Mercredi, juin 21, 2023
General Health, Health, Health Technology, Telemedicine, Virtual Medicine, Health Insurance, Informatics, American Society for Clinical Laboratory Science, University, College, CHOP, Texas A&M University, College of American Pathologists, Multimedia, Associate, Public sector, Organization, American Board of Commissioners for Foreign Missions, Pathology, FACMG, AI, Association for Molecular Pathology v. Myriad Genetics, Inc., Veritas Genetics, Medical genetics, Antibiotics, Genomics, Doctor of Philosophy, Genetics

LetsGetChecked, a global healthcare solutions company, announced today the appointment of Avni Santani, PhD, FACMG, to Chief Genomics Officer.

Key Points: 
  • LetsGetChecked, a global healthcare solutions company, announced today the appointment of Avni Santani, PhD, FACMG, to Chief Genomics Officer.
  • She joins the team from Veritas Genetics, a pioneering genomics company that was acquired by LetsGetChecked in 2022.
  • Dr. Santani holds a Ph.D. in Genetics from Texas A&M University and is board-certified in clinical laboratory genetics and genomics by the American Board of Medical Genetics and Genomics (ABMGG).
  • “I am delighted to be continuing my work in genetics with LetsGetChecked,” said Dr. Avni Santani, Chief Genomics Officer at LetsGetChecked.

hc1 Provides Thought Leadership During 2023 Joint Annual Meeting (JAM)

Retrieved on: 
Mardi, mai 23, 2023
MLS, JAM, Society, Clinical Laboratory, Lab, Health, Overalls, AGT, DCLS, Crystal ball, American Society for Clinical Laboratory Science, ASCP, Maxwell, Novant Health, Laboratory, Medical device

INDIANAPOLIS, May 23, 2023 /PRNewswire/ -- Experts from hc1, the leader in identifying real-time insights and risk signals in complex laboratory data, will take the stage during the Joint Annual Meeting (JAM) of the American Society for Clinical Laboratory Science (ASCLS), Association of Genetic Technologists (AGT), and Society of American Federal Medical Laboratory Scientists (SAFMLS), taking place in Providence, RI, June 26-30, 2023. hc1 experts will share their expertise on unlocking the lab's true power and helping laboratories extend their capabilities to optimize operations and inform testing and treatment decisions.

Key Points: 
  • During the session on Wednesday, June 28, at 8 a.m.
  • hc1 director, high value care, Adam Sajewich, and hc1 senior product manager, John Moyer, will also take the stage on Wednesday, June 28, at 9:15 a.m.
  • To learn more about connecting with hc1 at the JAM, visit info.hc1.com/labjam-2023 .
  • For more information on the JAM and to secure a spot, visit here .

Altasciences Expands Laboratory Capabilities in Columbia

Retrieved on: 
Mardi, février 14, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, Biomarker, Mass spectrometry, American Society for Clinical Laboratory Science, Flow cytometry, Vaccine, Fine chemical

Altasciences’ laboratory facilities in Columbia, MO, are undergoing a significant expansion, with completion expected this year.

Key Points: 
  • Altasciences’ laboratory facilities in Columbia, MO, are undergoing a significant expansion, with completion expected this year.
  • The new 8,000-square-foot space will mirror Altasciences’ current bioanalytical laboratory in Laval, Québec, with state-of-the-art equipment and bioanalytical capabilities.
  • “We are very excited about the laboratory expansion at our Columbia site.
  • “At Altasciences, we continue to increase capacity in support of our strategic growth plan, and look forward to the completion of this new laboratory to supplement our existing North American service offering,” stated Andy Brown, Columbia Site Director, at Altasciences.

Sitero Launches Biosafety Advisory Board, Naming Renowned Experts to Provide Guidance on Biosafety Compliance

Retrieved on: 
Mardi, janvier 10, 2023
Government, American College, Associate, Research, CDC, Plum Island Animal Disease Center, Merck, COVID-19, Laboratory, Federation, NBAF, IBC, CBSP, Growth, Select agent, Colorado State University, American Society for Clinical Laboratory Science, Environment, PPE, Biorisk, N95, National Institutes of Health Office of Science Policy, University, ABSA, Duke University School of Medicine, Biomedicine, RBP, NIH, Biocontainment, Pharmaceutical industry, Medical device, Biosafety, Safety

MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.

Key Points: 
  • MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.
  • The board will advise Sitero on its biosafety services, helping ensure that the company provides industry-leading support for biosafety compliance.
  • The Sitero Biosafety Advisory board is the latest investment that Sitero is making in their Biosafety and IBC offerings due to their recent and expected continued growth in the space.
  • "Their efforts will be instrumental in delivering best practices in biosafety to inform our work at Sitero and advance the biosafety profession."

The American Society for Clinical Pathology Expands List of Commonly Used Tests Physicians and Patients Should Question in Collaboration with ASCLS and ASM

Retrieved on: 
Mardi, novembre 8, 2022
Plasma, Viral hepatitis, Human, Physician, Publication, Industry, Immunoglobulin G, Society, Patient, CMA Code of Ethics and Professionalism, Consumer, Professional, DLM, Decision-making, ASCP, Glycated hemoglobin, ENA, Certification, Disease, Connective tissue disease, EBV, Marie Cassidy, Neutropenia, Autoimmune hepatitis, INR, Student, Policy, Education, Urine, Partnership, Chlamydia trachomatis, American Society for Clinical Laboratory Science, ANA, Pathology, Neisseria gonorrhoeae, Medicine, DOAC, Choosing Wisely, ASM, Coeliac disease, Knowledge, MPH, AIH, Pharmaceutical industry, Medical imaging, Vaccine, Ethics, MD, Chlamydia

The lists of targeted, evidence-based recommendations are designed to support conversations between patients and physicians about what care is really necessary.

Key Points: 
  • The lists of targeted, evidence-based recommendations are designed to support conversations between patients and physicians about what care is really necessary.
  • The new Choosing Wisely recommendations, developed by ASCP in collaboration with ASCLS, include:
    1.Don't repeat HbA1c testing within 3 months of a previous result.
  • 2.Don't perform an extensive work-up in otherwise healthy neutropenic patients of African or Middle Eastern ancestry prior to Duffy-null phenotype testing.
  • The American Society for Microbiology (ASM) is the largest single life science society, composed of 30,000 scientists and health professionals.

Altasciences Expands Laboratory Capabilities in Columbia

Retrieved on: 
Mercredi, octobre 19, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Clinical Trials, Other Health, Biotechnology, Drug development, American Society for Clinical Laboratory Science, Medical writing, Mass spectrometry, Biostatistics, Biomarker, Flow cytometry, Data management, Pharmaceutical industry

Altasciences laboratory facilities in Columbia, MO, are undergoing a significant expansion, with completion expected in 2023.

Key Points: 
  • Altasciences laboratory facilities in Columbia, MO, are undergoing a significant expansion, with completion expected in 2023.
  • The new 8,000-square-foot space will mirror Altasciences current bioanalytical laboratory in Laval, Qubec, with state-of-the-art equipment and bioanalytical capabilities.
  • We are very excited about the laboratory expansion at our Columbia site.
  • At Altasciences, we continue to increase capacity in support of our strategic growth plan, and look forward to the completion of this new laboratory to supplement our existing North American service offering, stated Andy Brown, Columbia Site Director, at Altasciences.

Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

Retrieved on: 
Jeudi, juin 9, 2022
Disorder, PBS, CTO, Society, Anemia, BMA, Cancer, Disease, Solution, Allergy, FDA, American Society for Clinical Laboratory Science, Patient, Hospital, U.S. FDA, Review, Diagnosis, TEL, Prevalence, Infection, Degenerative disease, Application, Blood, Medical device, Medical imaging

TEL AVIV, Israel, June 9, 2022 /PRNewswire/ -- Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, announced today that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.

Key Points: 
  • Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.
  • The majority of these tests are performed manually, but Scopio's disruptive Full-Field PBS morphology solution completely eliminates the need for additional manual microscopic examination.
  • Solving the tradeoff between field-of-view and resolution, Scopio enables labs to assess and analyze cell morphology at unprecedented scale and depth.
  • Scopio Labs' FDA-cleared, CE-marked Full-Field Peripheral Blood Smear applications are in full commercial use across the U.S. and Europe.

Cardinal Health honors top clinical laboratory professionals

Retrieved on: 
Mercredi, avril 27, 2022
MHA, COVID-19, Association, College, Research, Cardinal, CAH, Diagnosis, Program, Patient safety, Efficiency, COVID-19 testing, National Geographic, School, Public health, American Association, Multimedia, RBC, Ohio State University Wexner Medical Center, Trust, Health, OSU, CNBC, Scene (filmmaking), MLS, Leukemia, Infection, Doctor of Philosophy, AHI, View, American Society for Clinical Laboratory Science, Cardinal Health, ASCP, American Association for Clinical Chemistry, Awareness, Medical laboratory, Workflow, Leadership, SVCM, Health technology, MPA, Safety, Ohio State University, CLS, Forbes, University, Comanche County, Laboratory, Family, AMT, Culture, Student, NYSE, Regent, Pharmaceutical industry, Medicine, Medical device, Kronos

DUBLIN, Ohio, April 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health care and patient outcomes through their research, diagnosis, innovation or advocacy.

Key Points: 
  • DUBLIN, Ohio, April 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health care and patient outcomes through their research, diagnosis, innovation or advocacy.
  • The list is part of celebrations surrounding the industry's annual Medical Laboratory Professionals Week, a more than 40-year-long tradition that celebrates lab professionals across all of health care.
  • "On behalf of Cardinal Health, I want to say thank you to lab professionals everywhere for their essential contributions to laboratory medicine."
  • (In 2015, Rohde was honored as the Cardinal Health urEssential Laboratory Professional of the Year , a now-retired award program that recognized the vital contributions medical laboratory professionals made to patient care.)

Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions

Retrieved on: 
Mardi, novembre 23, 2021
Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Consulting, Professional Services, Immunochemistry, Trial of the century, Industry, PK, Data management, GCP, RG2, American Society for Clinical Laboratory Science, Flow cytometry, Immunology, Â, Biostatistics, Medical writing, GLP, Biotechnology, CL2, Knowledge, Drug development, Pharmaceutical industry

Altasciences , a leading drug development solution company, announced today the completion of a second expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.

Key Points: 
  • Altasciences , a leading drug development solution company, announced today the completion of a second expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services.
  • At Altasciences One Laboratory Sciences, we accelerate our clients programs by seamlessly integrating our new state-of-the-art bioanalytical lab with our preclinical and clinical studies, added Dr. Lynne Le Sauteur, Vice President, Laboratory Sciences.
  • With this expansion, Altasciences ligand binding assay tripled its square footage and will add to its employee base.
  • Altasciences uses innovative and cost-effective approaches to develop or customize ligand binding assays for the quantitative determination of biologics and small-molecule therapeutic products.